Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 01)
Doxazosin
Product Images NDC 50090-4004
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-4004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Doxazosin Tablets (A308818e E36c 4431 Bf51 274650c38cb0 02)
This appears to be a medical study, providing data on the maximum flow rate of urine in patients with benign prostatic hyperplasia, and the effectiveness of different doses of doxazosin. The study reports symptoms scores and mean changes in flow rate for patients receiving either placebo or different doses of doxazosin during 3 different trials. The studies also used different methods to evaluate the efficacy of doxazosin, including the AUA questionnaire and the Modified Boyarsky questionnaire. The study involved hypertensive patients and observed the effectiveness of doxazosin in treating BPH.*
Doxazosin Tablets, Usp (A308818e E36c 4431 Bf51 274650c38cb0 03)
This appears to be a table or chart with various measurements related to medical treatment. It includes columns labeled "Mean Change," "Maxiumum UrveryFiow," and "Scoresfom el Rale." Without additional context, it's difficult to determine what exactly these measurements represent.*
Label Image (Lbl500904004)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
